(en) M. Taylor, K. Mackay, J. Murphy, A. McIntosh, C. McIntosh, S. Anderson et K. Welch, «Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland», BMJ Open, vol.2, no4, , e000774–e000774 (DOI10.1136/bmjopen-2011-000774, lire en ligne, consulté le )
«Stupéfiants. Une «cousine de la kétamine»: l’Australie en alerte après la découverte d’une drogue inconnue», Courrier international, (lire en ligne, consulté le )
Eunice Yuen, Steven Swanson et Jeffrey M. Witkin, «Prediction of human efficacious antidepressant doses using the mouse forced swim test», Pharmacology, Biochemistry, and Behavior, vol.161, , p.22-29 (ISSN1873-5177, PMID28888484, DOI10.1016/j.pbb.2017.09.002, lire en ligne, consulté le ).
Chittaranjan Andrade, «Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions», The Journal of Clinical Psychiatry, vol.78, no7, , e858-e861 (ISSN1555-2101, PMID28858450, DOI10.4088/JCP.17f11802, lire en ligne, consulté le ).
Jelen L.A. et Stone J.M., Ketamine for depression, Int. Rev. Psychiatry, mai 2021, 33 (3), 207-228, DOI10.1080/09540261.2020.1854194, Epub 11 février 2021, PMID33569971 (consulté le 30 décembre 2022).
Yinghong Jiang, Yiqiang Wang, Xiaoran Sun et Bo Lian, «Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model», Brain and Behavior, vol.7, no8, , e00749 (ISSN2162-3279, PMID28828210, PMCIDPMC5561310, DOI10.1002/brb3.749, lire en ligne, consulté le )
Linda Nguyen, Anna L. Scandinaro et Rae R. Matsumoto, «Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice», Pharmacology, Biochemistry, and Behavior, (ISSN1873-5177, PMID28916283, DOI10.1016/j.pbb.2017.09.005, lire en ligne, consulté le ).
Paul Glue, Natalie J. Medlicott, Sarah Harland et Shona Neehoff, «Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders», Journal of Psychopharmacology (Oxford, England), , p.269881117705089 (ISSN1461-7285, PMID28441895, DOI10.1177/0269881117705089, lire en ligne, consulté le ).
Samuel Fanta, Mari Kinnunen, Janne T. Backman et Eija Kalso, «Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing», European Journal of Clinical Pharmacology, vol.71, no4, , p.441–447 (ISSN1432-1041, PMID25724645, DOI10.1007/s00228-015-1826-y, lire en ligne, consulté le )
Marco Zuin, Gianluca Rigatelli, Fabio Dell'Avvocata et Giuseppe Faggian, «Ketamine and midazolam differently impact post-intubation hemodynamic profile when used as induction agents during emergency airway management in hemodynamically stable patients with ST elevation myocardial infarction», Heart and Vessels, (ISSN1615-2573, PMID28889210, DOI10.1007/s00380-017-1049-5, lire en ligne, consulté le )
Aleksandar Lj Obradovic, Navya Atluri, Lorenza Dalla Massara et Azra Oklopcic, «Early Exposure to Ketamine Impairs Axonal Pruning in Developing Mouse Hippocampus», Molecular Neurobiology, (ISSN1559-1182, PMID28840469, DOI10.1007/s12035-017-0730-0, lire en ligne, consulté le )
Yanan Li, Xinran Li, Cen Guo et Lina Li, «Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats», Oncotarget, vol.8, no19, , p.30956–30970 (ISSN1949-2553, PMID28415680, PMCIDPMC5458180, DOI10.18632/oncotarget.16042, lire en ligne, consulté le )
Runtao Ding, Yanning Li, Ao Du et Hao Yu, «Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity», Scientific Reports, vol.6, , p.38771 (ISSN2045-2322, PMID27934938, PMCIDPMC5146946, DOI10.1038/srep38771, lire en ligne, consulté le )
Pen-Hua Su, Yan-Zin Chang et Jia-Yuh Chen, «Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair», Pediatrics and Neonatology, vol.51, no5, , p.279–284 (ISSN1875-9572, PMID20951358, DOI10.1016/S1875-9572(10)60054-X, lire en ligne, consulté le )
(en) Peggy Sau-Kwan Chu, Wai-Kit Ma, Simon Chun-Wing Wong, Ringo Wing-Hong Chu, Cheung-Hing Cheng, Shun Wong, Johnny Man-li Tse, Fei-Lung Lau, Ming-Kwong Yiu et Chi-Wai Man1, «The destruction of the lower urinary tract by ketamine abuse: a new syndrome?», BJU International, vol.102, , p.1616-1622 (DOI10.1111/j.1464-410X.2008.07920.x, résumé)
(en) M. Taylor, K. Mackay, J. Murphy, A. McIntosh, C. McIntosh, S. Anderson et K. Welch, «Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland», BMJ Open, vol.2, no4, , e000774–e000774 (DOI10.1136/bmjopen-2011-000774, lire en ligne, consulté le )
(en) Ana M. del Álamo, Ron E. Mandsager, Thomas W. Riebold et Mark E. Payton, «Evaluation of intravenous administration of alfaxalone, propofol, and ketamine-diazepam for anesthesia in alpacas», Veterinary Anaesthesia and Analgesia, vol.42, no1, , p.72–82 (ISSN1467-2995, PMID24834969, DOI10.1111/vaa.12170)
(en) Carolina H. Riccó et Natalia Henao-Guerrero, «Cardiovascular effects of orotracheal intubation following anesthetic induction with propofol, ketamine-propofol, or ketamine-diazepam in premedicated dogs», Journal of the American Veterinary Medical Association, vol.244, no8, , p.934–939 (ISSN1943-569X, PMID24697769, DOI10.2460/javma.244.8.934)
Eunice Yuen, Steven Swanson et Jeffrey M. Witkin, «Prediction of human efficacious antidepressant doses using the mouse forced swim test», Pharmacology, Biochemistry, and Behavior, vol.161, , p.22-29 (ISSN1873-5177, PMID28888484, DOI10.1016/j.pbb.2017.09.002, lire en ligne, consulté le ).
Chittaranjan Andrade, «Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions», The Journal of Clinical Psychiatry, vol.78, no7, , e858-e861 (ISSN1555-2101, PMID28858450, DOI10.4088/JCP.17f11802, lire en ligne, consulté le ).
Yinghong Jiang, Yiqiang Wang, Xiaoran Sun et Bo Lian, «Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model», Brain and Behavior, vol.7, no8, , e00749 (ISSN2162-3279, PMID28828210, PMCIDPMC5561310, DOI10.1002/brb3.749, lire en ligne, consulté le )
Linda Nguyen, Anna L. Scandinaro et Rae R. Matsumoto, «Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice», Pharmacology, Biochemistry, and Behavior, (ISSN1873-5177, PMID28916283, DOI10.1016/j.pbb.2017.09.005, lire en ligne, consulté le ).
Paul Glue, Natalie J. Medlicott, Sarah Harland et Shona Neehoff, «Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders», Journal of Psychopharmacology (Oxford, England), , p.269881117705089 (ISSN1461-7285, PMID28441895, DOI10.1177/0269881117705089, lire en ligne, consulté le ).
Samuel Fanta, Mari Kinnunen, Janne T. Backman et Eija Kalso, «Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing», European Journal of Clinical Pharmacology, vol.71, no4, , p.441–447 (ISSN1432-1041, PMID25724645, DOI10.1007/s00228-015-1826-y, lire en ligne, consulté le )
Marco Zuin, Gianluca Rigatelli, Fabio Dell'Avvocata et Giuseppe Faggian, «Ketamine and midazolam differently impact post-intubation hemodynamic profile when used as induction agents during emergency airway management in hemodynamically stable patients with ST elevation myocardial infarction», Heart and Vessels, (ISSN1615-2573, PMID28889210, DOI10.1007/s00380-017-1049-5, lire en ligne, consulté le )
M. Shimoyama, N. Shimoyama, C. E. Inturrisi et K. Elliott, «Oral ketamine produces a dose-dependent CNS depression in the rat», Life Sciences, vol.60, no1, , PL9–14 (ISSN0024-3205, PMID8995536, lire en ligne, consulté le )
Aleksandar Lj Obradovic, Navya Atluri, Lorenza Dalla Massara et Azra Oklopcic, «Early Exposure to Ketamine Impairs Axonal Pruning in Developing Mouse Hippocampus», Molecular Neurobiology, (ISSN1559-1182, PMID28840469, DOI10.1007/s12035-017-0730-0, lire en ligne, consulté le )
Yanan Li, Xinran Li, Cen Guo et Lina Li, «Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats», Oncotarget, vol.8, no19, , p.30956–30970 (ISSN1949-2553, PMID28415680, PMCIDPMC5458180, DOI10.18632/oncotarget.16042, lire en ligne, consulté le )
Runtao Ding, Yanning Li, Ao Du et Hao Yu, «Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity», Scientific Reports, vol.6, , p.38771 (ISSN2045-2322, PMID27934938, PMCIDPMC5146946, DOI10.1038/srep38771, lire en ligne, consulté le )
W. Ma, Y.-Y. Cao, S. Qu et S.-S. Ma, «Remote ischemic preconditioning provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain», European Review for Medical and Pharmacological Sciences, vol.20, no23, , p.4972–4979 (ISSN2284-0729, PMID27981535, lire en ligne, consulté le )
Pen-Hua Su, Yan-Zin Chang et Jia-Yuh Chen, «Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair», Pediatrics and Neonatology, vol.51, no5, , p.279–284 (ISSN1875-9572, PMID20951358, DOI10.1016/S1875-9572(10)60054-X, lire en ligne, consulté le )
Danja Strümper, Wiebke Gogarten, Marcel E. Durieux et Kristian Hartleb, «The effects of S+-ketamine and racemic ketamine on uterine blood flow in chronically instrumented pregnant sheep», Anesthesia and Analgesia, vol.98, no2, , p.497–502, table of contents (ISSN0003-2999, PMID14742394, lire en ligne, consulté le )
M. S. M. Wai, P. Luan, Y. Jiang et W. M. Chan, «Long term ketamine and ketamine plus alcohol toxicity - what can we learn from animal models?», Mini Reviews in Medicinal Chemistry, vol.13, no2, , p.273–279 (ISSN1875-5607, PMID22512581, lire en ligne, consulté le )
(en) Ana M. del Álamo, Ron E. Mandsager, Thomas W. Riebold et Mark E. Payton, «Evaluation of intravenous administration of alfaxalone, propofol, and ketamine-diazepam for anesthesia in alpacas», Veterinary Anaesthesia and Analgesia, vol.42, no1, , p.72–82 (ISSN1467-2995, PMID24834969, DOI10.1111/vaa.12170)
(en) Carolina H. Riccó et Natalia Henao-Guerrero, «Cardiovascular effects of orotracheal intubation following anesthetic induction with propofol, ketamine-propofol, or ketamine-diazepam in premedicated dogs», Journal of the American Veterinary Medical Association, vol.244, no8, , p.934–939 (ISSN1943-569X, PMID24697769, DOI10.2460/javma.244.8.934)
Eunice Yuen, Steven Swanson et Jeffrey M. Witkin, «Prediction of human efficacious antidepressant doses using the mouse forced swim test», Pharmacology, Biochemistry, and Behavior, vol.161, , p.22-29 (ISSN1873-5177, PMID28888484, DOI10.1016/j.pbb.2017.09.002, lire en ligne, consulté le ).
Chittaranjan Andrade, «Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions», The Journal of Clinical Psychiatry, vol.78, no7, , e858-e861 (ISSN1555-2101, PMID28858450, DOI10.4088/JCP.17f11802, lire en ligne, consulté le ).
Jelen L.A. et Stone J.M., Ketamine for depression, Int. Rev. Psychiatry, mai 2021, 33 (3), 207-228, DOI10.1080/09540261.2020.1854194, Epub 11 février 2021, PMID33569971 (consulté le 30 décembre 2022).
Yinghong Jiang, Yiqiang Wang, Xiaoran Sun et Bo Lian, «Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model», Brain and Behavior, vol.7, no8, , e00749 (ISSN2162-3279, PMID28828210, PMCIDPMC5561310, DOI10.1002/brb3.749, lire en ligne, consulté le )
Linda Nguyen, Anna L. Scandinaro et Rae R. Matsumoto, «Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice», Pharmacology, Biochemistry, and Behavior, (ISSN1873-5177, PMID28916283, DOI10.1016/j.pbb.2017.09.005, lire en ligne, consulté le ).
Paul Glue, Natalie J. Medlicott, Sarah Harland et Shona Neehoff, «Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders», Journal of Psychopharmacology (Oxford, England), , p.269881117705089 (ISSN1461-7285, PMID28441895, DOI10.1177/0269881117705089, lire en ligne, consulté le ).
Samuel Fanta, Mari Kinnunen, Janne T. Backman et Eija Kalso, «Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing», European Journal of Clinical Pharmacology, vol.71, no4, , p.441–447 (ISSN1432-1041, PMID25724645, DOI10.1007/s00228-015-1826-y, lire en ligne, consulté le )
Marco Zuin, Gianluca Rigatelli, Fabio Dell'Avvocata et Giuseppe Faggian, «Ketamine and midazolam differently impact post-intubation hemodynamic profile when used as induction agents during emergency airway management in hemodynamically stable patients with ST elevation myocardial infarction», Heart and Vessels, (ISSN1615-2573, PMID28889210, DOI10.1007/s00380-017-1049-5, lire en ligne, consulté le )
M. Shimoyama, N. Shimoyama, C. E. Inturrisi et K. Elliott, «Oral ketamine produces a dose-dependent CNS depression in the rat», Life Sciences, vol.60, no1, , PL9–14 (ISSN0024-3205, PMID8995536, lire en ligne, consulté le )
Aleksandar Lj Obradovic, Navya Atluri, Lorenza Dalla Massara et Azra Oklopcic, «Early Exposure to Ketamine Impairs Axonal Pruning in Developing Mouse Hippocampus», Molecular Neurobiology, (ISSN1559-1182, PMID28840469, DOI10.1007/s12035-017-0730-0, lire en ligne, consulté le )
Yanan Li, Xinran Li, Cen Guo et Lina Li, «Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats», Oncotarget, vol.8, no19, , p.30956–30970 (ISSN1949-2553, PMID28415680, PMCIDPMC5458180, DOI10.18632/oncotarget.16042, lire en ligne, consulté le )
Runtao Ding, Yanning Li, Ao Du et Hao Yu, «Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity», Scientific Reports, vol.6, , p.38771 (ISSN2045-2322, PMID27934938, PMCIDPMC5146946, DOI10.1038/srep38771, lire en ligne, consulté le )
W. Ma, Y.-Y. Cao, S. Qu et S.-S. Ma, «Remote ischemic preconditioning provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain», European Review for Medical and Pharmacological Sciences, vol.20, no23, , p.4972–4979 (ISSN2284-0729, PMID27981535, lire en ligne, consulté le )
Pen-Hua Su, Yan-Zin Chang et Jia-Yuh Chen, «Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair», Pediatrics and Neonatology, vol.51, no5, , p.279–284 (ISSN1875-9572, PMID20951358, DOI10.1016/S1875-9572(10)60054-X, lire en ligne, consulté le )
Danja Strümper, Wiebke Gogarten, Marcel E. Durieux et Kristian Hartleb, «The effects of S+-ketamine and racemic ketamine on uterine blood flow in chronically instrumented pregnant sheep», Anesthesia and Analgesia, vol.98, no2, , p.497–502, table of contents (ISSN0003-2999, PMID14742394, lire en ligne, consulté le )
M. S. M. Wai, P. Luan, Y. Jiang et W. M. Chan, «Long term ketamine and ketamine plus alcohol toxicity - what can we learn from animal models?», Mini Reviews in Medicinal Chemistry, vol.13, no2, , p.273–279 (ISSN1875-5607, PMID22512581, lire en ligne, consulté le )
(en) Ana M. del Álamo, Ron E. Mandsager, Thomas W. Riebold et Mark E. Payton, «Evaluation of intravenous administration of alfaxalone, propofol, and ketamine-diazepam for anesthesia in alpacas», Veterinary Anaesthesia and Analgesia, vol.42, no1, , p.72–82 (ISSN1467-2995, PMID24834969, DOI10.1111/vaa.12170)
(en) Carolina H. Riccó et Natalia Henao-Guerrero, «Cardiovascular effects of orotracheal intubation following anesthetic induction with propofol, ketamine-propofol, or ketamine-diazepam in premedicated dogs», Journal of the American Veterinary Medical Association, vol.244, no8, , p.934–939 (ISSN1943-569X, PMID24697769, DOI10.2460/javma.244.8.934)
FABRICE, HUBERT, BENOIT REYNAUD, L’ASSOCIATION ROMIFIDINE-NALBUPHINE DANS LA CHIRURGIE DEBOUT CHEZ LE CHEVAL: EVALUATION DE LA SÉDATION (thèse pour le doctorat vétérinaire), (lire en ligne).